{"id":"W4388047619","doi":"10.1136/jitc-2023-sitc2023.0778","title":"778 TILVANCE-301, a phase 3 study of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy combined with pembrolizumab (pembro) vs pembro alone in treatment-naïve unresectable or metastatic melanoma","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Melanoma; Cancer; Internal medicine; Oncology; Surgery; Immunotherapy; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008332377,0.0006795656,0.001498428,0.0006646824,0.0002033568,0.0001197015,0.0002592789,0.0001308498,0.0002199782],"category_scores_gemma":[0.0002598752,0.0004904941,0.0001591771,0.001479921,0.0003957777,0.0002957295,0.00007189978,0.0003978394,0.00002705014],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000396103,"about_ca_system_score_gemma":0.001659521,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002294102,"about_ca_topic_score_gemma":0.000772726,"domain_scores_codex":[0.9955819,0.0003560807,0.001033492,0.0009229711,0.00109182,0.00101379],"domain_scores_gemma":[0.9971659,0.0004370276,0.0004030165,0.0008994964,0.0002240455,0.0008705383],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.08262718,0.01303833,0.07585815,0.001727283,0.001993002,0.01113614,0.01794103,0.001208886,0.7816778,0.00004844465,0.001093923,0.01164979],"study_design_scores_gemma":[0.2165749,0.05501272,0.0678672,0.001080115,0.0006370976,0.001033996,0.01105502,0.005960967,0.6359932,0.000167736,0.003288739,0.001328303],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942449,0.0008478409,0.000002604066,0.0002012539,0.00011031,0.003005099,0.00005666526,0.0001777147,0.001353642],"genre_scores_gemma":[0.9922957,0.0007857413,0.0004036712,0.0001140943,0.0000929589,0.0003522287,0.0001203009,0.000156502,0.005678794],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1456846,"threshold_uncertainty_score":0.9997547,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04680987990646559,"score_gpt":0.3167563591817601,"score_spread":0.2699464792752946,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}